Long-term Follow-up in Patients Affected With Acrofacial Vitiligo
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01459055
Recruitment Status : Unknown
Verified May 2016 by Caio Cesar Silva de Castro, Irmandade da Santa Casa de Misericordia de Curitiba. Recruitment status was: Not yet recruiting
First Posted : October 25, 2011
Last Update Posted : May 3, 2016
Irmandade da Santa Casa de Misericordia de Curitiba
Information provided by (Responsible Party):
Caio Cesar Silva de Castro, Irmandade da Santa Casa de Misericordia de Curitiba
Acrofacial vitiligo is a clinical form of vitiligo characterized by macules in distal digits, periorificial-facial and ano-genital areas. Vitiligo European Task Force classifies vitiligo as generalized or localized; generalized vitiligo may be further sub-divided into acrofacial, vulgaris and universalis, and localized vitiligo, into segmental and focal. Some authors do not believe that acrofacial is a real vitiligo clinical form, considering it as an initial form of vulgaris vitiligo. The aim of this study is to follow early- diagnosed acrofacial patients during ten years in order to define if these patients will maintain this clinical form or will evolute to a more severe clinical form.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients of both genders affected by acrofacial vitiligo diagnosed by one single dermatologist.
Patients of both genders, aged older than years, able to understand and provide written informed consent and able to allow compliance at the treatment and the requirements of the protocol;
Presence of acrofacial vitiligo;
Able to comprehend and willing to provide written informed consent in accordance with institutional and regulatory guidelines.
1- Subjects assessed as not suitable for the study in the opinion of the investigator